Ann Setser

1.4k total citations
11 papers, 1.0k citations indexed

About

Ann Setser is a scholar working on Oncology, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Ann Setser has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Economics and Econometrics and 2 papers in Molecular Biology. Recurrent topics in Ann Setser's work include Economic and Financial Impacts of Cancer (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and HER2/EGFR in Cancer Research (2 papers). Ann Setser is often cited by papers focused on Economic and Financial Impacts of Cancer (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and HER2/EGFR in Cancer Research (2 papers). Ann Setser collaborates with scholars based in United States, France and Canada. Ann Setser's co-authors include Ethan Basch, Andy Trotti, A. Dimitrios Colevas, Elise A. Olsen, Mario E. Lacouture, A. D. Colevas, Alice P. Chen, Jonathan Cotliar, Benjamin C. Garden and Milan J. Anadkat and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Journal of the American Academy of Dermatology.

In The Last Decade

Ann Setser

11 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Setser United States 9 456 250 167 161 153 11 1.0k
April Teitelbaum United States 15 476 1.0× 128 0.5× 172 1.0× 133 0.8× 127 0.8× 31 960
Vincenzo Montesarchio Italy 17 373 0.8× 229 0.9× 155 0.9× 108 0.7× 45 0.3× 69 847
Marwan Ghosn Lebanon 19 786 1.7× 458 1.8× 212 1.3× 188 1.2× 83 0.5× 122 1.4k
Leona Holmberg United States 21 457 1.0× 229 0.9× 290 1.7× 73 0.5× 108 0.7× 44 1.5k
Sophie Papa United Kingdom 23 952 2.1× 287 1.1× 281 1.7× 120 0.7× 98 0.6× 57 1.8k
Hampig Raphaël Kourié Lebanon 21 1.0k 2.3× 424 1.7× 389 2.3× 244 1.5× 199 1.3× 166 1.8k
Maria Rosaria Valerio Italy 21 745 1.6× 310 1.2× 186 1.1× 308 1.9× 97 0.6× 94 1.4k
L.M. Jost Switzerland 20 651 1.4× 506 2.0× 218 1.3× 334 2.1× 70 0.5× 39 1.6k
Norbert Marschner Germany 25 1.3k 2.8× 649 2.6× 407 2.4× 258 1.6× 170 1.1× 153 2.2k
Amy Rapkiewicz United States 15 266 0.6× 229 0.9× 200 1.2× 153 1.0× 88 0.6× 48 1.3k

Countries citing papers authored by Ann Setser

Since Specialization
Citations

This map shows the geographic impact of Ann Setser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Setser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Setser more than expected).

Fields of papers citing papers by Ann Setser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Setser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Setser. The network helps show where Ann Setser may publish in the future.

Co-authorship network of co-authors of Ann Setser

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Setser. A scholar is included among the top collaborators of Ann Setser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Setser. Ann Setser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chen, Alice P., Ann Setser, Milan J. Anadkat, et al.. (2012). Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0. Journal of the American Academy of Dermatology. 67(5). 1025–1039. 274 indexed citations
2.
Setser, Ann & Elizabeth Ness. (2011). An innovative, web-based reporting system for serious adverse events developed by the cancer therapy evaluation program (CTEP), National Cancer Institute (NCI). 10 indexed citations
3.
Lacouture, Mario E., Michael L. Maitland, Siegfried Segaert, et al.. (2010). A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Supportive Care in Cancer. 18(4). 509–522. 107 indexed citations
4.
Trotti, Andy, A. Dimitrios Colevas, Ann Setser, & Ethan Basch. (2007). Patient-Reported Outcomes and the Evolution of Adverse Event Reporting in Oncology. Journal of Clinical Oncology. 25(32). 5121–5127. 248 indexed citations
5.
Colevas, A. D. & Ann Setser. (2004). The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials. Journal of Clinical Oncology. 22(14_suppl). 6098–6098. 85 indexed citations
6.
Hubbard, S M & Ann Setser. (2001). The cancer informatics infrastructure: A new initiative of the national cancer institute. Seminars in Oncology Nursing. 17(1). 55–61. 4 indexed citations
7.
Ivy, S. Percy, Susan G. Arbuck, & Ann Setser. (1999). #420 Common toxicity criteria (CTC) version 2.0. Journal of Pediatric Hematology/Oncology. 21(4). 326–326. 44 indexed citations
8.
Pai, Lee H., Robert E. Wittes, Ann Setser, Mark C. Willingham, & Ira Pastan. (1996). Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxin. Nature Medicine. 2(3). 350–353. 159 indexed citations
9.
Politi, Pedro M., William Dahut, Harry Ford, et al.. (1995). Phase I clinical trial of continuous infusion cyclopentenyl cytosine. Cancer Chemotherapy and Pharmacology. 36(6). 513–523. 37 indexed citations
10.
Politi, Pedro M., William Dahut, Harry Ford, et al.. (1995). Phase I clinical trial of continuous infusion cyclopentenyl cytosine. Cancer Chemotherapy and Pharmacology. 36(6). 513–523. 2 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by April Teitelbaum Breakdown of academic impact, for papers by Vincenzo Montesarchio Breakdown of academic impact, for papers by Marwan Ghosn Breakdown of academic impact, for papers by Leona Holmberg Breakdown of academic impact, for papers by Sophie Papa Breakdown of academic impact, for papers by Hampig Raphaël Kourié Breakdown of academic impact, for papers by Maria Rosaria Valerio Breakdown of academic impact, for papers by L.M. Jost Breakdown of academic impact, for papers by Norbert Marschner Breakdown of academic impact, for papers by Amy Rapkiewicz
Rankless by CCL
2026